Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Aug 15;192(4):523-5.
doi: 10.1164/rccm.201502-0235LE.

Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease

Salman H Siddiqui  1 , Alessandro Guasconi  2 , Jørgen Vestbo  3 , Paul Jones  4 , Alvar Agusti  5   6 , Pierluigi Paggiaro  7 , Jadwiga A Wedzicha  8 , Dave Singh  9
Affiliations
Randomized Controlled Trial

Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease

Salman H Siddiqui et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Adjusted chronic obstructive pulmonary disease (COPD) exacerbation rate (events/patient/year) with beclomethasone dipropionate plus formoterol fumarate (BDP/FF) (black) and FF (gray) stratified by baseline blood eosinophil (EOS) quartile. (B) Adjusted mean difference from baseline to 48 weeks with BDP/FF (black) and FF (gray) in predose morning FEV1 (L) at 48 weeks stratified by baseline blood EOS quartile. (C) Adjusted mean difference from baseline to 48 weeks with BDP/FF (black) and FF (gray) in total St. George’s Respiratory Questionnaire (SGRQ) at 48 weeks, stratified by baseline blood EOS quartile.
See this image and copyright information in PMC

References

    1. Agusti A. The path to personalised medicine in COPD. Thorax. 2014;69:857–864. - PubMed
    1. Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R ECLIPSE investigators. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44:1697–1700. - PubMed
    1. Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, McCormick M, Haldar K, Kebadze T, Duvoix A, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184:662–671. - PubMed
    1. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173:1114–1121. - PubMed
    1. Bafadhel M, McKenna S, Terry S, Mistry V, Pancholi M, Venge P, Lomas DA, Barer MR, Johnston SL, Pavord ID, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2012;186:48–55. - PMC - PubMed

Publication types

MeSH terms